Anaphylatoxin

Jump to: navigation, search

WikiDoc Resources for Anaphylatoxin

Articles

Most recent articles on Anaphylatoxin

Most cited articles on Anaphylatoxin

Review articles on Anaphylatoxin

Articles on Anaphylatoxin in N Eng J Med, Lancet, BMJ

Media

Powerpoint slides on Anaphylatoxin

Images of Anaphylatoxin

Photos of Anaphylatoxin

Podcasts & MP3s on Anaphylatoxin

Videos on Anaphylatoxin

Evidence Based Medicine

Cochrane Collaboration on Anaphylatoxin

Bandolier on Anaphylatoxin

TRIP on Anaphylatoxin

Clinical Trials

Ongoing Trials on Anaphylatoxin at Clinical Trials.gov

Trial results on Anaphylatoxin

Clinical Trials on Anaphylatoxin at Google

Guidelines / Policies / Govt

US National Guidelines Clearinghouse on Anaphylatoxin

NICE Guidance on Anaphylatoxin

NHS PRODIGY Guidance

FDA on Anaphylatoxin

CDC on Anaphylatoxin

Books

Books on Anaphylatoxin

News

Anaphylatoxin in the news

Be alerted to news on Anaphylatoxin

News trends on Anaphylatoxin

Commentary

Blogs on Anaphylatoxin

Definitions

Definitions of Anaphylatoxin

Patient Resources / Community

Patient resources on Anaphylatoxin

Discussion groups on Anaphylatoxin

Patient Handouts on Anaphylatoxin

Directions to Hospitals Treating Anaphylatoxin

Risk calculators and risk factors for Anaphylatoxin

Healthcare Provider Resources

Symptoms of Anaphylatoxin

Causes & Risk Factors for Anaphylatoxin

Diagnostic studies for Anaphylatoxin

Treatment of Anaphylatoxin

Continuing Medical Education (CME)

CME Programs on Anaphylatoxin

International

Anaphylatoxin en Espanol

Anaphylatoxin en Francais

Business

Anaphylatoxin in the Marketplace

Patents on Anaphylatoxin

Experimental / Informatics

List of terms related to Anaphylatoxin

Editor-In-Chief: C. Michael Gibson, M.S., M.D. [1]

Anaphylatoxins, or anaphylotoxins, are fragments (C3a, C4a or C5a) that are produced during the pathways of the complement system.

Direct and indirect functions

Most notable is the ability to trigger degranulation of (release of substances from) mast cells or basophils, which is an important part of the immune system in all kinds of inflammation and especially as part of defense against parasites. If the degranulation is too strong, it can cause allergic reactions.

Anaphylatoxins indirectly mediate:

Examples

Important anaphylatoxins:

  • C3a is not as strong as C5a, but stronger than C4a and can trigger degranulation of Mast-cells and serve as a chemotactic targeting molecule for eosinophile granulocytes.
  • C4a is the least active anaphylatoxin
  • C5a is the strongest toxin in the row, it is a very strong mediator of inflammation.
    • co-stimulation of C3b at times of phagocytosis (not possible without C5a).
    • Chemotactor and activator for granulocytes in general and macrophages
    • stimulates respiratory burst in Neutrophils
    • increases vascular permeability
    • contracts smooth muscle cells
    • activates mastcells to churn out Histamine and TNF-Alpha

Terminology

Although some drugs (morphine, codeine, synthetic ACTH) and some neurotransmitters (norepinephrine, substance P) are important mediators of degranulation of mast cells or basophils, they are generally not called anaphylatoxins. This term is reserved only for fragments of the complement.

See also

External links

de:Anaphylatoxin


Linked-in.jpg